Publications by authors named "E Cacace"

Article Synopsis
  • * The study analyzed existing data on E. coli and established a new metric to differentiate between cross-resistance and collateral sensitivity, uncovering 404 cross-resistance and 267 collateral-sensitivity interactions—tripling known cases.
  • * By confirming many of these interactions through experimental methods and identifying specific mutants, the research showed that some drug pairs can display both resistance types, and using collateral-sensitive pairs can help prevent antibiotic resistance from developing in laboratory settings.
View Article and Find Full Text PDF

BackgroundCarbapenemase-producing Enterobacterales are a public health threat worldwide and OXA-48 is the most prevalent carbapenemase in Germany and western Europe. However, the molecular epidemiology of OXA-48 in species other than and remains poorly understood.AimTo analyse the molecular epidemiology of OXA-48 and OXA-48-like carbapenemases in species (spp.

View Article and Find Full Text PDF

Drug combinations can expand options for antibacterial therapies but have not been systematically tested in Gram-positive species. We profiled ~8,000 combinations of 65 antibacterial drugs against the model species Bacillus subtilis and two prominent pathogens, Staphylococcus aureus and Streptococcus pneumoniae. Thereby, we recapitulated previously known drug interactions, but also identified ten times more novel interactions in the pathogen S.

View Article and Find Full Text PDF

Background: Physical activity in the elderly is recommended by international guidelines to protect against cognitive decline and functional impairment.

Objective: This Randomized Controlled Trial (RCT) was set up to verify whether medium-intensity physical activity in elderly people living in the community is effective in improving cognitive performance.

Design: RCT with parallel and balanced large groups.

View Article and Find Full Text PDF

Antibiotics are used to fight pathogens but also target commensal bacteria, disturbing the composition of gut microbiota and causing dysbiosis and disease. Despite this well-known collateral damage, the activity spectrum of different antibiotic classes on gut bacteria remains poorly characterized. Here we characterize further 144 antibiotics from a previous screen of more than 1,000 drugs on 38 representative human gut microbiome species.

View Article and Find Full Text PDF